Rapid Methods and Automation in Microbiology and Immunology

  • K.-O. Habermehl
Conference proceedings

Table of contents

  1. Front Matter
    Pages I-XVI
  2. Time Realities in the Evaluation of Vaccines for Safety and Efficacy

  3. Hybridization Technology in Diagnostics

    1. M. Ranki, M. Laaksonen, A. Palva, A.-C. Syvänen, M. Virtanen, H. Söderlund
      Pages 34-42
    2. G. W. Bornkamm, S. Wiest, C. Desgranges
      Pages 48-56
    3. L. S. Tompkins, P. A. Mickelsen, N. Troup
      Pages 68-72
    4. H. Wolf, M. Haus, U. Leser, S. Modrow, M. Motz, S.-Y. Gu et al.
      Pages 73-82
  4. Application of Monoclonal Antibodies. Hybridoma Technology

  5. Rapid Diagnosis by IgM-Detection

  6. Physical Detection of Microorganisms

  7. Chromatographic Analysis of Microbial Components

  8. Isolation of Microorganisms

  9. Antigen Detection and Identification

About these proceedings


Rapid progress in molecular biology, genetic engineering, and basic research in immunology has opened up new possibilities for application to diagnostic procedures and to clinical research. In a short period a new era of diagnosis dawned, covering nearly all fields of microbiology, immunology, and food technology. In consequence of this rapid development, scientists of many disciplines are involved studying infections of humans, animals, and plants or working in technical microbiology. The application of the newest findings of basic research to diagnostic work and to clinical research covers nearly all fields of microbiology and immunology. Moreover, it underlines the close relationship between diagnosis, therapy, and epidemiology. An outstanding example of these connections is given by the recent development of hepatitis B vaccine. The discovery and identification of a non­ cultivable agent by physicochemical and immunological methods were the heralds of a new era in the prevention of infectious diseases. This book provides an up-to-date, comprehensive review of developments and future aspects in various fields. I am convinced that the authors have succeeded in furnishing a large variety of new ideas and possibilities. K.-O. HABERMEHL Contents Time Realities in the Evaluation of Vaccines for Safety and Efficacy The Evaluation of Vaccines M. R. HILLEMAN . . . . .


Hepatitis diseases hepatitis B immunology infection infections infectious infectious disease infectious diseases microbiology molecular biology vaccine

Editors and affiliations

  • K.-O. Habermehl
    • 1
  1. 1.Institut für Klinische und Experimentelle VirologieFreie Universität BerlinBerlin 45Germany

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1985
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-69945-0
  • Online ISBN 978-3-642-69943-6
  • Buy this book on publisher's site